Paraneoplastic pemphigus treated with dexamethasone/cyclophosphamide pulse therapy

European Journal of Dermatology

Volumn 8, Issue 8, 1998, Pages 551-553

  Becker, Lorenz R ^a   Bastian, Boris C ^a   Wesselmann, Ulrich ^a   Karl, Susanne ^a   Hamm, Henning ^a   Bröcker, Eva B ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Blister, immunosuppression; Bullous disease; Macroglobulinemia; Paraneoplasia; Paraneoplastic pemphigus; Treatment; Waldenstrom's macroglobulinemia

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

AGED; ARTICLE; AUTOIMMUNE DISEASE; BULLOUS SKIN DISEASE; CASE REPORT; CORTICOSTEROID THERAPY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; ORAL DRUG ADMINISTRATION; PARANEOPLASTIC SYNDROME; PEMPHIGUS; TREATMENT OUTCOME; WALDENSTROEM MACROGLOBULINEMIA;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; MALE; PARANEOPLASTIC SYNDROMES; PEMPHIGUS; TREATMENT OUTCOME; WALDENSTROM MACROGLOBULINEMIA;

EID: 0032436866     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Anhalt GJ, Kim S, Stanley JR, et al. Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990; 323: 1729-35.
2. Anhalt JG. Pemphigus and the pemphigus disease spectrum. In: Cutaneous medicine and surgery. Arndt AK, Robinson JK, LeBoit PE, Wintroub BU, eds. 1. Edition., W.B. Sounders Company, 1996: 658-63.
3. Horn D, Anhalt GJ. Histologic features of paraneoplastic pemphigus. Arch Dermatol 1992; 128: 1091-5.
4. Zillikens D, Bröcker E-B. Paraneoplastischer Pemphigus. Hautarzt 1994; 45: 827-33.
5. Stahle-Beckdahl M, Heblad M-A, Skoglundt C, Fagerholm P, et al. Paraneoplastic pemphigus: a report of two patients responding to cyclosporin. Eur J Dermatol 1995; 5: 671-5.
6. Mayers SJ, Varley GA, Meisler DM, Camisa C, Wander AH. Conjunctival involvement in paraneoplastic pemphigus. Am J Ophthalmol 1992; 114: 621-4.
7. Camisa C, Helm TN, Liu YC, Venezuela R, et al. Paraneoplastic pemphigus: a report of three cases including one long time survivor. J Am Acad Dermatol 1992; 27: 547-53.
8. Helm TN, Camisa C, Valenzuela R, Allen CM. Paraneoplastic pemphigus. Oral Surg Oral Med Oral Pathol 1993; 75: 209-13.
9. Lam S, Stone MS, Goeken JA, Massicotte SJ, et al. Paraneoplastic pemphigus, cicatricial conjunctivitis, and acanthosis nigrans with pachdermatoglyphy in a patient with bronchogenic squamous cell carcinoma. Ophthalmologia 1992; 99: 108-13.
10. Mehregan DR, Oursler JR, Leiferman KM, Muller SA, et al. Paraneoplastic pemphigus: a subset of patients with pemphigus and neoplasia. J Cutan Pathol 1993; 20: 203-10.
11. Izaki S, Yoshizawa Y, Hashimoto T, Korman NJ, et al. Paraneoplastic pemphigus: report of case. J Dermatol 1996; 23: 397-404.
12. Pasricha LS, Thanzama J, Khan UK. Intermittent high dose dexamethasone-cyclophosphamide therapy for pemphigus. Br J Dermatol 1988; 119: 73-7.
13. Kaur S, Kanwar AJ. Dexamethasone-cyclophosphamide pulse therapy in pemphigus. Int J Dermatol 1990; 29: 371-4.
14. Appelhans M, Bonsmann G, Örge C. Bröcker E-B Dexamethason-Cyclophosphamid-Stoßtherapie bei blasenbildenden Autoimmundermatosen. Hautarzt 1993; 44: 143-7.
15. Pandya AG, Warren KJ, Bergstresser PR. Cicatricial pemphigoid successfully treated with pulse intravenous cyclophosphamide. Arch Dermatol 1997; 133: 245-7.
16. Werth PV. Pulse intravenous cyclophosphamide for treatment of autoimmune blistering disease. Arch Dermatol 1997; 133: 229-30.